Answers are grounded in this paper and cite their sources.
I have always stressed in the Journal the need for cooperation between urologist, and medical and radiation oncologists in the treatment of prostate cancer. The two opening mini‐reviews this month were written by medical oncologists (the papers were reviewed by two American urologists) and they present their views on how adjuvant and neoadjuvant treatments can improve outcomes in prostate cancer. Genetic susceptibility to renal cancer is very much in our minds at present, and our increasing knowledge of this subject has allowed us to develop new understanding about the condition. Authors from France have written a very thorough and scientific review on low‐penetrance genetic susceptibility to renal cancer. Finally, a review from Korea on the management of neurogenic bladder and quality of life in spinal cord injury completes this section.
No takes yet. Share an insight, caveat, or question.
Mazhar et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: